Dejin Bio

China
Fucheng, Shanxi, China

Company profile

Dejin Bio company profile

Dejin Bio is an innovative company focused on the research, development, production, and sales of recombinant botulinum toxin, dedicated to developing high-performance, cost-effective botulinum toxin products using synthetic biology technology.

Business identity

Operating status
Active
Company type
For Profit
Founded
2023-02-01, Month

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Last funding
Series A / 2026-01-20
Last equity funding
Series A
Investors
1
Lead investors
1

Founders and investors

Lead investors

Highlight Capital

Investors

Highlight Capital